Literature DB >> 26088718

Common Models, Different Approaches.

Joshua J Gagne1.   

Abstract

Mesh：

Year:  2015        PMID： 26088718     DOI： 10.1007/s40264-015-0313-9

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  8 in total

1.  Validation of a common data model for active safety surveillance research.

Authors:  J Marc Overhage; Patrick B Ryan; Christian G Reich; Abraham G Hartzema; Paul E Stang
Journal:  J Am Med Inform Assoc       Date:  2011-10-28       Impact factor: 4.497

2.  The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.

Authors:  Richard Platt; Ryan M Carnahan; Jeffrey S Brown; Elizabeth Chrischilles; Lesley H Curtis; Sean Hennessy; Jennifer C Nelson; Judith A Racoosin; Melissa Robb; Sebastian Schneeweiss; Sengwee Toh; Mark G Weiner
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

3.  Design considerations, architecture, and use of the Mini-Sentinel distributed data system.

Authors:  Lesley H Curtis; Mark G Weiner; Denise M Boudreau; William O Cooper; Gregory W Daniel; Vinit P Nair; Marsha A Raebel; Nicolas U Beaulieu; Robert Rosofsky; Tiffany S Woodworth; Jeffrey S Brown
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

4.  Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership.

Authors:  Paul E Stang; Patrick B Ryan; Judith A Racoosin; J Marc Overhage; Abraham G Hartzema; Christian Reich; Emily Welebob; Thomas Scarnecchia; Janet Woodcock
Journal:  Ann Intern Med       Date:  2010-11-02       Impact factor: 25.391

5.  Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.

Authors:  Preciosa M Coloma; Martijn J Schuemie; Gianluca Trifirò; Rosa Gini; Ron Herings; Julia Hippisley-Cox; Giampiero Mazzaglia; Carlo Giaquinto; Giovanni Corrao; Lars Pedersen; Johan van der Lei; Miriam Sturkenboom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-11-08       Impact factor: 2.890

6.  The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.

Authors:  Morten Andersen; Ulf Bergman; Nam-Kyong Choi; Tobias Gerhard; Cecilia Huang; Jessica Jalbert; Michio Kimura; Tomomi Kimura; Kiyoshi Kubota; Edward Chia-Cheng Lai; Nobuhiro Ooba; Byung-Joo Park; Nicole Pratt; Elizabeth E Roughead; Tsugumichi Sato; Soko Setoguchi; Ju-Young Shin; Anders Sundström; Yea-Huei Kao Yang
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-05-08       Impact factor: 2.890

7.  A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.

Authors:  Yihua Xu; Xiaofeng Zhou; Brandon T Suehs; Abraham G Hartzema; Michael G Kahn; Yola Moride; Brian C Sauer; Qing Liu; Keran Moll; Margaret K Pasquale; Vinit P Nair; Andrew Bate
Journal:  Drug Saf       Date:  2015-08       Impact factor: 5.606

8.  CNODES: the Canadian Network for Observational Drug Effect Studies.

Authors:  Samy Suissa; David Henry; Patricia Caetano; Colin R Dormuth; Pierre Ernst; Brenda Hemmelgarn; Jacques Lelorier; Adrian Levy; Patricia J Martens; J Michael Paterson; Robert W Platt; Ingrid Sketris; Gary Teare
Journal:  Open Med       Date:  2012-10-30
  8 in total
  3 in total

1.  Transformation and Evaluation of the MIMIC Database in the OMOP Common Data Model: Development and Usability Study.

Authors:  Nicolas Paris; Adrien Parrot; Antoine Lamer
Journal:  JMIR Med Inform       Date:  2021-12-14

2.  Building a framework for the evaluation of knowledge translation for the Canadian Network for Observational Drug Effect Studies.

Authors:  Ingrid S Sketris; Nancy Carter; Robyn L Traynor; Dorian Watts; Kim Kelly
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-02-20       Impact factor: 2.890

3.  Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation.

Authors:  Alexandra Pacurariu; Kelly Plueschke; Patricia McGettigan; Daniel R Morales; Jim Slattery; Dagmar Vogl; Thomas Goedecke; Xavier Kurz; Alison Cave
Journal:  BMJ Open       Date:  2018-09-05       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.